Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
61,356,952
-
Shares change
-
-1,718,727
-
Total reported value, excl. options
-
$42,953,245
-
Value change
-
-$1,247,523
-
Put/Call ratio
-
51%
-
Number of buys
-
21
-
Number of sells
-
28
-
Price
-
$0.7001
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2025
As of 31 Mar 2025 Seres Therapeutics, Inc. - COMMON STOCK (MCRB) had 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,356,952 shares of stock of the company.
Largest 10 holders included Flagship Pioneering Inc., FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Vontobel Holding Ltd., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and STATE STREET CORP.
This table shows 59 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.